Patents by Inventor Andy Ofer GOREN

Andy Ofer GOREN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10111821
    Abstract: Methods are disclosed for administering electromagnetic radiation (EMR), which may include filtering EMR from part of the EMR spectrum while allowing passage of EMR at a desired wavelength range. Uses may include the treatment of such conditions as psoriasis, vitiligo, pruritus, acne, vitamin-D deficiency and atopic dermatitis. Topical creams, sprays, or other compositions may be used, with or without dosimeters, or in conjunction with an application, which calculates local UV exposure and other factors relating to dosage.
    Type: Grant
    Filed: December 31, 2013
    Date of Patent: October 30, 2018
    Assignee: Applied Biology, Inc.
    Inventors: Andy Ofer Goren, John McCoy
  • Patent number: 9588118
    Abstract: Apparatuses are disclosed for performing calorimetric assays with plucked human hair using a device adapted for that purpose. This device may include a transparent reaction vessel connected via a capillary tube to a burst pack, and connected via another capillary tube to a funnel, into which a plucked human hair may be placed.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 7, 2017
    Assignee: Follea International
    Inventors: Andy Ofer Goren, John McCoy, Daniel Hafid
  • Publication number: 20140335537
    Abstract: Apparatuses are disclosed for performing calorimetric assays with plucked human hair using a device adapted for that purpose. This device may include a transparent reaction vessel connected via a capillary tube to a burst pack, and connected via another capillary tube to a funnel, into which a plucked human hair may be placed.
    Type: Application
    Filed: April 7, 2014
    Publication date: November 13, 2014
    Applicant: Follea International Ltd.
    Inventors: Andy Ofer Goren, John McCoy, Daniel Hafid
  • Publication number: 20140309247
    Abstract: Methods, processes, systems, and apparatuses are disclosed for detecting biomarkers associated with the inflammation response in the pilosebaceous unit of the human scalp using plucked human hair and an enzyme activity assay which may for example be colorimetric or fluorometric.
    Type: Application
    Filed: April 15, 2013
    Publication date: October 16, 2014
    Inventors: Andy Ofer Goren, John McCoy
  • Publication number: 20140220609
    Abstract: Methods, processes, systems, and apparatuses are disclosed for predicting minoxidil response in the treatment of androgenetic alopecia based on colorimetric assay for sulfotransferase activity. In particular, SULT1A1 activity may be used as an indicator of minoxidil response. A genetic test for alleles of the SULT1A1 gene may be performed to provide a more personalized therapy.
    Type: Application
    Filed: April 8, 2014
    Publication date: August 7, 2014
    Applicant: FOLLEA INTERNATIONAL LTD.
    Inventors: Andy Ofer Goren, John McCoy
  • Patent number: 8758993
    Abstract: Methods, processes, systems, and apparatuses are disclosed for predicting anti-androgen therapy response in the treatment of androgenetic alopecia based on a fluorometric assay and proteomics.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: June 24, 2014
    Assignee: Global Life Science Partners Limited
    Inventors: Andy Ofer Goren, John McCoy
  • Publication number: 20140121732
    Abstract: Methods are disclosed for administering electromagnetic radiation (EMR), which may include filtering EMR from part of the EMR spectrum while allowing passage of EMR at a desired wavelength range. Uses may include the treatment of such conditions as psoriasis, vitiligo, pruritus, acne, vitamin-D deficiency and atopic dermatitis. Topical creams, sprays, or other compositions may be used, with or without dosimeters, or in conjunction with an application, which calculates local UV exposure and other factors relating to dosage.
    Type: Application
    Filed: December 31, 2013
    Publication date: May 1, 2014
    Applicant: Applied Biology, Inc.
    Inventors: Andy Ofer Goren, John McCoy
  • Patent number: 8691518
    Abstract: Methods, processes, systems, and apparatuses are disclosed for predicting minoxidil response in the treatment of androgenetic alopecia based on colorimetric assay.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: April 8, 2014
    Assignee: Global Life Science Partners Limited
    Inventors: Phillip Y. Tam, Andy Ofer Goren
  • Publication number: 20130310730
    Abstract: Methods are disclosed for administering electromagnetic radiation (EMR), which may include filtering EMR from part of the EMR spectrum while allowing passage of EMR at a desired wavelength. A fluorescent component may be included, which absorbs EMR at one wavelength and emits EMR at the desired wavelength. Uses may include the treatment of acne. Pruritus may also be treated by allowing the passage to the skin of a particular UV wavelength from sunlight, which has an immunosuppressive effect, while protecting the skin from other harmful UV radiation.
    Type: Application
    Filed: July 22, 2013
    Publication date: November 21, 2013
    Applicant: Applied Biology, Inc.
    Inventors: Andy Ofer Goren, John McCoy
  • Publication number: 20130115180
    Abstract: Methods and compositions are disclosed for administering electromagnetic radiation (EMR), for therapeutic or cosmetic purposes, or for purposes of curing a polymeric material.
    Type: Application
    Filed: November 5, 2012
    Publication date: May 9, 2013
    Inventors: Andy Ofer Goren, John McCoy
  • Publication number: 20130095484
    Abstract: Methods, processes, systems, and apparatuses are disclosed for predicting anti-androgen therapy response in the treatment of androgenetic alopecia based on a fluorometric assay and proteomics.
    Type: Application
    Filed: October 15, 2012
    Publication date: April 18, 2013
    Inventors: Andy Ofer Goren, John McCoy
  • Publication number: 20120232045
    Abstract: Methods and systems are described for prediction of a patient's response to a drug for treating androgenetic skin disorders such as alopecia, acne, and hirsutism. For a given drug such as anti-androgens and 5-alpha-reductase inhibitors, and a given dosage, the likely responsiveness of that drug and dosage may be determined, for example, by generating a set of patient scores based on a patient profile, including genetic sample information, and comparing that scores to a set of reference information.
    Type: Application
    Filed: May 21, 2012
    Publication date: September 13, 2012
    Inventors: Andy Ofer Goren, Sharon Keene
  • Publication number: 20120077214
    Abstract: Methods, processes, systems, and apparatuses are disclosed for predicting minoxidil response in the treatment of androgenetic alopecia based on colorimetric assay.
    Type: Application
    Filed: September 26, 2011
    Publication date: March 29, 2012
    Inventors: Phillip Y. Tam, Andy Ofer Goren
  • Publication number: 20090306537
    Abstract: A system for predicting a woman's current position in her menstrual or ovulation cycle includes a baseline voice characteristics storage module in which first set of characteristics of the woman's voice at a known time relative to her menstrual or ovulation cycle is stored, an analysis module for receiving for analyzing a voice sample from the woman and generating a second set of characteristics of the woman's voice, a comparison module for comparing the first and second sets of characteristics, and a results module for providing a prediction of the woman's current position in her menstrual or ovulation cycle based on the comparison.
    Type: Application
    Filed: June 9, 2009
    Publication date: December 10, 2009
    Inventor: Andy Ofer Goren
  • Publication number: 20090233954
    Abstract: Methods and systems are described for prediction of a patient's response to a drug for treating androgenetic skin disorders such as alopecia, acne, and hirsutism. For a given drug such as anti-androgens and 5-alpha-reductase inhibitors, and a given dosage, the likely responsiveness of that drug and dosage may be determined, for example, by generating a set of patient scores based on a patient profile, including genetic sample information, and comparing that scores to a set of reference information.
    Type: Application
    Filed: August 29, 2008
    Publication date: September 17, 2009
    Inventors: Andy Ofer GOREN, Sharon Keene